Silvina Dutruel

Dr. Silvina Dutruel

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2019 in Clinical Imaging
Verified
Journal Article
Closed access
JIJana Ivanidze
Jana Ivanidze
MRMichelle Roytman
Michelle Roytman
ASArielle Sasson
Arielle Sasson
MSMyrto Skafida
Myrto Skafida
TFThomas J. Fahey
Thomas J. Fahey
SDSilvina Dutruel
Silvina Dutruel

18 October 2023 in Journal of the American College of Radiology
Verified
Journal Article
Closed access
SDSilvina Dutruel
Silvina Dutruel
KHKeith D. Hentel
Keith D. Hentel
EHElizabeth M. Hecht
Elizabeth M. Hecht
Nadja KadomNadja Kadom
Nadja Kadom

17 March 2020 in Abdominal Radiology
Verified
Journal Article
Closed access
PDF file
SDSilvina Dutruel
Silvina Dutruel
SJSunil Jeph
Sunil Jeph
DMDaniel Jason Aaron Margolis
Daniel Jason Aaron Margolis
NWNatasha Wehrli
Natasha Wehrli

17 February 2025 in Journal of Imaging
Verified
Journal Article
Open access
PDF file
DYDivya Yadav
Divya Yadav
EOElisabeth O’dwyer
Elisabeth O’dwyer
MAMatthew Agee
Matthew Agee
SDSilvina Dutruel
Silvina Dutruel
SMSonia Mahajan
Sonia Mahajan
SCSandra Huicochea Castellanos
Sandra Huicochea Castellanos
FDG PET/CT provides complementary metabolic information with greater sensitivity and specificity than conventional imaging modalities for evaluating local recurrence, nodal, and distant metastases in patients with cervical cancer. PET/CT can also be used in radiation treatment planning, which is the mainstay of treatment. With the implementation of various oncological guidelines, FDG PET/CT has been utilized more frequently in patient management and prognostication. Newer PET tracers targeting the tumor microenvironment offer valuable biologic insights to elucidate the mechanism of treatment resistance and tumor aggressiveness and identify the high-risk patients. Artificial intelligence and machine learning approaches have been utilized more recently in metastatic disease detection, response assessment, and prognostication of cervical cancer.